Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic developments in autoimmune thyroid disease: an evolutionary process.

Abigail A Zeitlin1, Matthew J Simmonds, Stephen C L Gough

  • 1Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham, B15 2TT, UK.

Clinical Endocrinology
|December 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myeloid Malignancies Beyond the Cell: Targeting the Tumour Microenvironment with Next-Generation Immunotherapies.

Cancers·2026
Same author

Alterations in calreticulin and CD47 expression dynamics in myeloid malignancies: therapeutic and prognostic implications in myelodysplastic syndromes and myeloproliferative neoplasms.

Haematologica·2025
Same author

The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2023
Same author

The contributions of insulin to science in medicine.

Diabetic medicine : a journal of the British Diabetic Association·2021
Same author

Current and future therapies for type 1 diabetes.

Diabetologia·2021
Same author

Genetic predictors of long-term graft function in kidney and pancreas transplant patients.

Briefings in functional genomics·2017
Same journal

Supraphysiological Glucocorticoid Doses and Pitfalls of Annual Biomarker Monitoring in Adults With CAH.

Clinical endocrinology·2026
Same journal

Subacute Thyroiditis in Denmark: A Nationwide Study of 1763 Cases.

Clinical endocrinology·2026
Same journal

Pubertal Dynamics of Sertoli and Leydig Cell Dysfunction in Klinefelter Syndrome.

Clinical endocrinology·2026
Same journal

Regarding Non-Classical Presentations of Rare Hereditary Hypoparathyroidism: A Case Series of CASR, GNA11, and GATA3 Mutations in Parathyroidology.

Clinical endocrinology·2026
Same journal

Dual Metabolic Burden of Polyendocrine Metabolic Ovarian Syndrome (PMOS) and Gestational Diabetes in Pregnancy: Impact on Neonatal Anthropometry: Insights From the Born in Bradford Cohort.

Clinical endocrinology·2026
Same journal

Preoperative CALLY Index for Identifying Atypical Parathyroid Tumors.

Clinical endocrinology·2026
See all related articles

Identifying genetic susceptibility for autoimmune thyroid disease (AITD) has advanced significantly. Researchers have mapped novel loci, including Human Leucocyte Antigen (HLA) and CTLA-4, improving our understanding of AITD risk factors.

Area of Science:

  • Immunogenetics
  • Autoimmune Diseases
  • Thyroid Research

Background:

  • Genetic factors contributing to autoimmune thyroid disease (AITD) have been challenging to identify.
  • Significant progress has been made in mapping susceptibility loci over the past two decades.

Purpose of the Study:

  • To review the identification and mapping of genetic loci associated with autoimmune thyroid disease (AITD).
  • To highlight key genetic discoveries and methodologies used in AITD research.

Main Methods:

  • Utilized traditional immunological methods to identify Human Leucocyte Antigen (HLA)/Major Histocompatibility Complex (MHC) associations.
  • Employed candidate gene methods to identify the CTLA-4 locus.
  • Conducted family-based linkage studies to map the PTPN22 gene.

Related Experiment Videos

  • Applied tagging strategies for common variation and tag single nucleotide polymorphisms (SNPs) to identify TSHR and CD25 loci.
  • Leveraged large-scale genome-wide association studies (GWAS) for multiple autoimmune diseases (AID).

    • Main Results:

    • The Human Leucocyte Antigen (HLA)/Major Histocompatibility Complex (MHC) region was the first identified genetic association with AITD.
    • The CTLA-4 gene region was the first non-MHC replicated susceptibility locus identified via candidate gene approach.
    • PTPN22, initially mapped as a type 1 diabetes locus, was replicated as a susceptibility gene for Graves' disease (GD).
    • TSHR was identified as the first GD-specific locus through comprehensive variation tagging.
    • CD25 was implicated as a susceptibility gene for GD using tag SNPs.

    Conclusions:

    • Multiple genetic loci, both MHC and non-MHC, contribute to AITD susceptibility.
    • Advancements in genetic methodologies, including GWAS, are crucial for discovering additional AITD risk genes.
    • Continued research is expected to further elucidate the genetic architecture of AITD and related autoimmune conditions.